Effect of Laughter Therapy on Surgical Stress, Oxygen Saturation, Pain and Comfort Level

January 9, 2024 updated by: Gülşah Kayserilioğlu, Ankara Yildirim Beyazıt University

Effect of Laughter Therapy Based on Kolcaba Comfort Theory on Surgical Stress, Oxygen Saturation, Pain and Comfort Level in Bariatric Surgery Patients

The aim of this study is to examine the effect of laughter therapy based on Kolcaba comfort theory, on surgical stress, oxygen saturation, pain and comfort level in bariatric surgery patients. The main questions it aims to answer are:

  1. Is there a significant difference between salivary cortisol levels of patients with and without laughter yoga before surgical intervention?
  2. Is there a significant difference between the blood glucose levels of patients who were and were not treated with laughter yoga before surgical intervention?
  3. Is there a significant difference between the mean scores on the perceived stress scale of patients who were and were not treated with laughter yoga before surgical intervention?
  4. Is there a significant difference between the oxygen saturation levels of patients with and without laughter yoga before surgical intervention?
  5. Is there a significant difference between the mean scores on the comfort level scale of patients who were and were not treated with laughter yoga before surgical intervention?
  6. Is there a significant difference between the mean scores on the pain scale of patients who were and were not treated with laughter yoga before surgical intervention?

The study population will consist of patients who will apply to the general surgery clinic of Düzce University Research and Application Center between June 2023 and April 2024, who will undergo bariatric surgery and agree to participate in the study. The data collected from these patients will be analyzed.

From the patients who meet the inclusion criteria and agree to participate in the study; experimental and control groups will be determined by simple randomization. They will be informed about the research (a 15-minute presentation prepared by the researcher explaining what laughter therapy is) and their verbal and written permission will be obtained.

The laughter yoga will be applied to experimanetal group. Every laughter yoga practice is 45 minutes long and is planned 3 times a week for a total of 6 sessions. Control group patients will take only routine nursing care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Düzce, Turkey
        • Düzce University Research and Application Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Those who can speak and understand Turkish,
  • Those who agreed to participate in the study,
  • Adult age group between 18 and 60 years old,
  • Those with pain intensity <2 according to the Visual Comparison Scale,
  • Those with time and place orientation,
  • Those without vision and hearing problems,
  • Those who are literate or have literate relatives,
  • Those without history of psychiatric illness,
  • Those without any history of psychotropic drug use and history,
  • Those without previous laughter yoga practice,
  • Those with a smartphone/computer/tablet,
  • Those who undergone laparoscopic sleeve gastrectomy surgery,
  • Those who can attend the trainings at the specified times so that cortisol is not affected by circadian rhythm,
  • Those who are able to comply with the collection of saliva samples,
  • American Society of Anesthesiologist (ASA) score I, II or III as assessed by physicians

Exclusion Criteria:

  • Those who speak Turkish but cannot understand,
  • Those who are under 18 and over 60 years of age,
  • Those who are not willing to participate in the study,
  • Those diagnosed with psychiatric illness,
  • Those with previous laughter yoga practice,
  • Those with physical limitations/respiratory problems who cannot perform yoga movements,
  • Those who have difficulty in doing breathing exercises due to deviated septum etc,
  • Those who have undergone abdominal surgery in the last six months
  • Hypothyroidism, hyperaldosteronism, pregnancy, malignancy, congestive heart failure, psychotic disorder, chronic liver failure, uncontrolled hypertension, glaucoma, herniation, nephrotic syndrome, type 2 diabetes mellitus, Patients with a diagnosis of chronic renal failure and continuous use of medication were excluded as salivary cortisol levels may be affected,
  • Those with an ASA score of 4,
  • Those who don't undergone laparoscopic sleeve gastrectomy surgery,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood glucose level
Time Frame: before first laughter therapy application
with blood glucose meter
before first laughter therapy application
Blood glucose level
Time Frame: after sixth laughter therapy application (preop first day)
with blood glucose meter
after sixth laughter therapy application (preop first day)
Blood glucose level
Time Frame: postop first day
with blood glucose meter
postop first day
Oxygen Saturation Level
Time Frame: before first laughter therapy application
with pulse oximetry
before first laughter therapy application
oxygen saturation level
Time Frame: after sixth laughter therapy application (preop first day)
with pulse oximetry
after sixth laughter therapy application (preop first day)
Oxygen Saturation Level
Time Frame: postop first day
with pulse oximetry
postop first day
Stress level
Time Frame: before first laughter therapy application
with Perceived Stress Scale-14, 0-56 (min-max), higher scores mean worse outcome
before first laughter therapy application
Stress level
Time Frame: after sixth laughter therapy application (preop first day)
with Perceived Stress Scale-14, 0-56 (min-max), higher scores mean worse outcome
after sixth laughter therapy application (preop first day)
Stress level
Time Frame: postop first day
with Perceived Stress Scale-14, 0-56 (min-max), higher scores mean worse outcome
postop first day
Pain level
Time Frame: before first laughter therapy application
with Visual Analog Scale, 0-10 (min-max), higher scores mean worse outcome
before first laughter therapy application
Pain level
Time Frame: after sixth laughter therapy application (preop first day)
with Visual Analog Scale, 0-10 (min-max), higher scores mean worse outcome
after sixth laughter therapy application (preop first day)
Pain level
Time Frame: postop first day
with Visual Analog Scale, 0-10 (min-max), higher scores mean worse outcome
postop first day
Comfort level
Time Frame: before first laughter therapy application
with General Comfort Questionaire, 48-192 (min-max), higher scores mean worse outcome
before first laughter therapy application
Comfort level
Time Frame: after sixth laughter therapy application (preop first day)
with General Comfort Questionaire, 48-192 (min-max), higher scores mean worse outcome
after sixth laughter therapy application (preop first day)
Comfort level
Time Frame: postop first day
with General Comfort Questionaire, 48-192 (min-max), higher scores mean worse outcome
postop first day
salivary cortisol sample
Time Frame: before first laughter therapy application
salivette cortisol
before first laughter therapy application
salivary cortisol sample
Time Frame: after sixth laughter therapy application (preop first day)
salivette cortisol
after sixth laughter therapy application (preop first day)
salivary cortisol sample
Time Frame: postop first day
salivette cortisol
postop first day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2022

Primary Completion (Actual)

September 15, 2023

Study Completion (Actual)

December 1, 2023

Study Registration Dates

First Submitted

June 22, 2023

First Submitted That Met QC Criteria

June 22, 2023

First Posted (Actual)

July 3, 2023

Study Record Updates

Last Update Posted (Estimated)

January 11, 2024

Last Update Submitted That Met QC Criteria

January 9, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ANKARAYBU-GKAYSERILIOGLU-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laughter Yoga

Clinical Trials on Laughter Therapy Based on Kolcaba Comfort Theory

3
Subscribe